Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Subhiksha Nandakumar
Observed names:
Nandakumar, Subhiksha,
S. Nandakumar
Institution:
Memorial Sloan Kettering Cancer Center
Observed institutions:
Center for Biologics Evaluation and Research,
United States Food and Drug Administration,
Memorial Sloan Kettering Cancer Center,
Cornell University,
Yale University,
Stanford Medicine,
Nurix (United States),
Weill Cornell Medicine,
McGill University,
Stanford University
show all 10
ORCID:
0000-0003-0258-3484
Observed ORCID:
0000-0003-0258-3484
OpenAlex ID:
A5080705644
Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients
2022
·
Bastien Nguyen
, Christopher Fong
, et al.
·
Cell
·
623
Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies
2018
·
James J. Harding
, Subhiksha Nandakumar
, et al.
·
Clinical Cancer Research
·
598
Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer
2023
·
Sarah P. Suehnholz
, Moriah H. Nissan
, et al.
·
Cancer Discovery
·
403
PDF
A Reference Viral Database (RVDB) To Enhance Bioinformatics Analysis of High-Throughput Sequencing for Novel Virus Detection
2018
·
Norman Goodacre
, Aisha Aljanahi
, et al.
·
mSphere
·
252
Automated real-world data integration improves cancer outcome prediction
2024
·
Justin Jee
, Christopher Fong
, et al.
·
Nature
·
183
Oncogenic Genomic Alterations, Clinical Phenotypes, and Outcomes in Metastatic Castration-Sensitive Prostate Cancer
2020
·
Konrad H. Stopsack
, Subhiksha Nandakumar
, et al.
·
Clinical Cancer Research
·
180
A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2)
2019
·
Ying Z. Mazzu
, Joshua Armenia
, et al.
·
Clinical Cancer Research
·
155
Pan-cancer Analysis of CDK12 Alterations Identifies a Subset of Prostate Cancers with Distinct Genomic and Clinical Characteristics
2020
·
Bastien Nguyen
, Jose Mauricio Mota
, et al.
·
European Urology
·
118
Significance of BRCA2 and RB1 Co-loss in Aggressive Prostate Cancer Progression
2019
·
Goutam Chakraborty
, Joshua Armenia
, et al.
·
Clinical Cancer Research
·
112
Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival
2025
·
Anna M. Varghese
, Maria A. Perry
, et al.
·
Nature Medicine
·
104
PDF
Genetic Ancestry Correlates with Somatic Differences in a Real-World Clinical Cancer Sequencing Cohort
2022
·
Kanika Arora
, Thinh N. Tran
, et al.
·
Cancer Discovery
·
82
BRCA mutational status shapes the stromal microenvironment of pancreatic cancer linking clusterin expression in cancer associated fibroblasts with HSF1 signaling
2022
·
Lee Shaashua
, Aviad Ben-Shmuel
, et al.
·
Nature Communications
·
79
PDF
Specific Mutations in APC, but Not Alterations in DNA Damage Response, Associate With Outcomes of Patients With Metastatic Colorectal Cancer
2020
·
Sebastian Mondaca
, Henry Walch
, et al.
·
Gastroenterology
·
70
Differences in Prostate Cancer Genomes by Self-reported Race: Contributions of Genetic Ancestry, Modifiable Cancer Risk Factors, and Clinical Factors
2021
·
Konrad H. Stopsack
, Subhiksha Nandakumar
, et al.
·
Clinical Cancer Research
·
58
The Impact of PIK3R1 Mutations and Insulin–PI3K–Glycolytic Pathway Regulation in Prostate Cancer
2022
·
Goutam Chakraborty
, Subhiksha Nandakumar
, et al.
·
Clinical Cancer Research
·
53
PDF
Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer
2020
·
Ying Z. Mazzu
, Joshua Armenia
, et al.
·
Molecular Oncology
·
40
PDF
Whole-Genome Sequence of the Spodoptera frugiperda Sf9 Insect Cell Line
2017
·
Subhiksha Nandakumar
, Hailun Ma
, et al.
·
Genome Announcements
·
40
PDF
Tumor Volume Growth Rates and Doubling Times during Active Surveillance of IDH-mutant Low-Grade Glioma
2023
·
Ankush Bhatia
, Raquel Moreno
, et al.
·
Clinical Cancer Research
·
35
PDF
Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series
2024
·
Nicolas Anselmino
, Estefania Labanca
, et al.
·
Clinical Cancer Research
·
32
PDF
A Phase II Study Assessing Long-term Response to Ibrutinib Monotherapy in Recurrent or Refractory CNS Lymphoma
2024
·
Christian Grommes
, Subhiksha Nandakumar
, et al.
·
Clinical Cancer Research
·
30
PDF
CDKN2A/B mutations and allele-specific alterations stratify survival outcomes in IDH-mutant astrocytomas
2023
·
Richard A. Hickman
, Erika Gedvilaite
, et al.
·
Acta Neuropathologica
·
26
PDF
Methylation‐associated miR‐193b silencing activates master drivers of aggressive prostate cancer
2019
·
Ying Z. Mazzu
, Yuki Yoshikawa
, et al.
·
Molecular Oncology
·
24
PDF
Attenuation of SRC Kinase Activity Augments PARP Inhibitor–mediated Synthetic Lethality in BRCA2 -altered Prostate Tumors
2020
·
Goutam Chakraborty
, Nabeela Khan Patail
, et al.
·
Clinical Cancer Research
·
23
Sharing data from the Human Tumor Atlas Network through standards, infrastructure and community engagement
2025
·
Ino de Bruijn
, Milen Nikolov
, et al.
·
Nature Methods
·
22
Real-world experience with circulating tumor DNA in cerebrospinal fluid from patients with central nervous system tumors
2024
·
Richard A. Hickman
, Alexandra M. Miller
, et al.
·
Acta Neuropathologica Communications
·
21
PDF
Show more works
View as search
Works count:
367
Citation count:
3,622
H-index:
23
I10-index:
35
Year
Topic
Type